Results 211 to 220 of about 70,860 (294)

Impact of achieving glycated hemoglobin targets on cardiovascular events/mortality: <i>Post-hoc</i> analysis of the nephropathy in diabetes type 2 trial. [PDF]

World J Diabetes
Caturano A, Simeon V, Galiero R, Russo V, De Nicola L, Chiodini P, Rinaldi L, Vetrano E, Salvatore T, Conte C, Acierno C, Sardu C, Marfella R, Minutolo R, Sasso FC.   +14 more
europepmc   +1 more source

Blood glucose and glycated hemoglobin evaluation: a populational study

Romanian Journal of Diabetes Nutrition and Metabolic Diseases, 2012
Adina Mitrea, Maria Mota, Daniela Patru, Amorin Remus Popa, Diana Protasiewicz, Robert Dinu, Cristina Muntean, Raluca Dina, Magda Sandu, Flavia Dinu, Betty Bornagel   +10 more
openaire   +1 more source

Discordant real‐world glycaemic outcomes with Omnipod™ 5 and MiniMed™ 780G in adults with type 1 diabetes: Why validated measures matter

Diabetes, Obesity and Metabolism, EarlyView.
Panagiotis Pavlou, Ananthi Anandhakrishnan, Kleoniki I. Athanasiadou, Anna Brackenridge, Yuk‐Fun Liu, Dulmini Kariyawasam, Thomas Johnston, Rosarie Atkinson, Rebecca Hyslop, Siobhan Pender, Janaka Karalliedde, Sufyan Hussain   +11 more
wiley   +1 more source

MiR‐210‐3p is upregulated in diabetic peripheral neuropathy and may be involved in the progression of the disease by targeting brain‐derived neurotrophic factor

Journal of Diabetes Investigation, EarlyView.
Elevated miR‐210‐3p expression was diagnostic for diabetic peripheral neuropathy (DPN) and served as an independent risk factor for DPN. miR‐210‐3p functioned by negatively regulating BDNF, and its inhibitor reversed hyperglycemia‐induced Schwann cell dysfunction, whereas BDNF knockdown eliminated this protective effect.
Yafei Zhao, Liu Wang, Dongcai Feng
wiley   +1 more source

Glycated Hemoglobin and Cardiovascular Disease in Patients Without Diabetes. [PDF]

J Clin Med
Jakubiak GK, Chwalba A, Basek A, Cieślar G, Pawlas N.   +4 more
europepmc   +1 more source

Is the Triglyceride-Glycated Hemoglobin Index Superior to Triglyceride-Glucose Index in Predicting Metabolic Syndrome in an American Adult Population [PDF]

Ishwarlal Jialal, Beverley Adams‐Huet
openalex   +1 more source

BALLAST study: A multicentre, open‐label, randomized‐controlled, 52‐week clinical trial of the efficacy and safety of luseogliflozin in older Japanese adults with type 2 diabetes receiving leucine‐enriched amino acid supplementation and physical exercise programme

Diabetes, Obesity and Metabolism, EarlyView.
Yoshihiro Takahashi, Makoto Hayashi, Takehiro Kato, Yukio Horikawa, Shin Tsunekawa, Hitoshi Kuwata, Yutaka Seino, Ryota Ogata, Kenta Murotani, Daisuke Yabe, BALLAST Study Group, Takehiro Kato, Makoto Hayashi, Hisashi Daido, Kouji Yamada, Takeshi Shimada, Kazuhisa Takami, Akihiko Sasaki, Toshiro Shibata, Shin‐ichi Kawachi, Nobutoshi Fushimi, Hiroyuki Niwa, Tomiko Horiya, Kijyun Nagata, Shun Ito   +24 more
wiley   +1 more source

Effect of switching from intermittently scanned continuous glucose monitoring to FreeStyle Libre 2 with real‐time continuous glucose monitoring and alert functionality

Journal of Diabetes Investigation, EarlyView.
Transitioning from FSL to FSL2 with rtCGM function improved sensor usage and glycemic control, particularly in patients with Type 1 diabetes. The duration required for improvement in continuous glucose monitoring‐related parameters varied by diabetes type, with early improvements observed in Type 1 diabetes and gradual improvements in Type 2 diabetes ...
Keiji Sugai, Junko Sasaki, Gakuyuki Tomizawa, Ryo Suzuki   +3 more
wiley   +1 more source

Analysis of the correlation between corneal and meibomian gland morphology and glycated hemoglobin levels in type 2 diabetes patients. [PDF]

BMC Ophthalmol
Li K, Han Y, Zhang Y, Ma Q, Niu JL, Fan F, Wang J.   +6 more
europepmc   +1 more source

Efficacy of probiotics (Bifidobacterium bifidum G9‐1) in patients with type 2 diabetes mellitus and chronic kidney disease complicated by constipation: An exploratory, multicenter, open‐label, single‐arm study (BIRDIE study)

Journal of Diabetes Investigation, EarlyView.
Bifidobacterium bifidum G9‐1 improved stool form, defecation frequency, and Quality of Life in patients with type 2 diabetes mellitus and chronic kidney disease complicated by constipation. ABSTRACT Introduction Although constipation is a major complication of type 2 diabetes mellitus and chronic kidney disease, evidence for its treatment in these ...
Fuki Ikeda, Junko Sato, Hidenori Yoshii, Masahiro Sugawara, Hiroaki Satoh, Yukiko Sugawara, Hirotsugu Uzawa, Daisuke Sugimoto, Reina Muto, Yuya Nishida, Hirotaka Watada   +10 more
wiley   +1 more source